Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
45.50
-0.08 (-0.17%)
Streaming Delayed Price
Updated: 11:26 AM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crispr Therapeutics Ag
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
29
30
Next >
Devon Energy, CRISPR Therapeutics, And Bullish On Berkshire Succession: CNBC's 'Final Trades'
May 10, 2023
On CNBC’s "Halftime Report Final Trades," Joseph Terranova of Virtus Investment Partners said CRISPR Therapeutics AG (NASDAQ: CRSP) reported strong
Via
Benzinga
Why CRISPR Therapeutics Stock Is on Fire Today
May 09, 2023
Thanks to the gene-editing pioneer having a pipeline chock-full of deep value and a possible regulatory approval on tap, investors are bidding up shares today.
Via
The Motley Fool
Something Happened In Biotech Last Week
May 08, 2023
Biotech stocks were more constructive last week with some sharp moves up.
Via
Talk Markets
This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett Stock
May 06, 2023
Vertex Pharmaceuticals faces limited competition in its core area of expertise, has a top-shelf CEO, and is building out a profoundly valuable pipeline of next-generation assets.
Via
The Motley Fool
1 Incredibly Undervalued Growth Stock to Buy Hand Over Fist in May
May 04, 2023
This market-beating biotech stock still has more room to run.
Via
The Motley Fool
Is It Too Late to Buy CRISPR Stock?
April 27, 2023
Five reasons to buy the promising biotech stock now.
Via
The Motley Fool
Why CRISPR Therapeutics Stock Is Marching Higher Today
April 17, 2023
This gene-editing stock has been heating up over the past week.
Via
The Motley Fool
What 14 Analyst Ratings Have To Say About CRISPR Therapeutics
April 17, 2023
Via
Benzinga
Is CRISPR Therapeutics Stock a Buy Now?
April 14, 2023
The biotech could soon be a commercial-stage company.
Via
The Motley Fool
3 Top Healthcare Stocks to Buy in May
May 04, 2023
You'll want to hold onto these innovative companies for the long term.
Via
The Motley Fool
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
May 02, 2023
Cathie Wood is loading up on these biotech stocks.
Via
The Motley Fool
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
May 01, 2023
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...
Via
Talk Markets
Why CRISPR Therapeutics Just Became an Even Better Buy
April 26, 2023
Is this a no-brainer investment to add to your portfolio?
Via
The Motley Fool
3 Biotech Stocks to Watch After Johnson & Johnson’s Earnings Beat
April 25, 2023
Discover the latest picks in the biotech industry with our article on 3 biotech stocks to watch after Johnson & Johnson’s earnings beat.
Via
InvestorPlace
CRISPR Therapeutics Is an Interesting 'Gene Editing Play for 2023' With Significant Upside, Says Analyst
April 13, 2023
Via
Benzinga
With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023
April 24, 2023
Via
Benzinga
The Best Stocks to Invest $20,000 in Right Now
April 23, 2023
You'll want to hold on to these top stocks for the long term.
Via
The Motley Fool
Buy the Dip: 2 Top Stocks to Snatch Up Now
April 23, 2023
You don't need to be too gutsy to buy these two stocks while they're down.
Via
The Motley Fool
3 Stocks With Huge Catalysts on the Way
April 22, 2023
Big news could mean big boosts for these stocks.
Via
The Motley Fool
2 Growth Stocks That Could Keep Growing for Decades
April 21, 2023
These businesses will likely only get larger in the future.
Via
The Motley Fool
Better Big Biotech Buy: Biogen vs. Vertex
April 20, 2023
One is slightly cheaper than the other.
Via
The Motley Fool
The Top 3 Biotech Stocks to Watch in 2023
April 20, 2023
Investors would be wise to keep an eye on the biotech boom, and these top biotech stocks to watch as we get deeper into 2023.
Via
InvestorPlace
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
April 20, 2023
Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is...
Via
Benzinga
3 High-Growth Biotech Stocks Poised for Success in 2023
April 18, 2023
If you look for growth opportunities wherever you can find them, there are some high-growth biotech stocks that could present an opportunity
Via
InvestorPlace
The Top Healthcare Stocks to Buy With $100
April 18, 2023
A small investment now may bring big results over time.
Via
The Motley Fool
Why Shares of Editas Medicine Rose Monday
April 17, 2023
The company is benefiting from positive news affecting other gene-editing stocks.
Via
The Motley Fool
Better Growth Stock: Axsome vs. CRISPR Therapeutics
April 16, 2023
These companies are both in the early days of their growth stories.
Via
The Motley Fool
Cathie Wood Just Bought More CRISPR Therapeutics (CRSP) Stock
April 13, 2023
Shares of CRSP stock are moving higher following an initiation of coverage by Cantor Fitzgerald and continued buys from Cathie Wood.
Via
InvestorPlace
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?
April 13, 2023
While CRSPR stock captured the spotlight for potentially encouraging drug data, the news lifted other gene-editing stocks.
Via
InvestorPlace
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
April 13, 2023
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
29
30
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.